These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22774981)

  • 1. K/B×N serum transfer arthritis is delayed and less severe in leukaemia inhibitory factor (LIF)-deficient mice.
    Upadhyay A; Senyschyn D; Santos L; Gu R; Carroll GJ; Jazayeri JA
    Clin Exp Immunol; 2012 Aug; 169(2):71-8. PubMed ID: 22774981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
    Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
    Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
    Martin P; Talabot-Ayer D; Seemayer CA; Vigne S; Lamacchia C; Rodriguez E; Finckh A; Smith DE; Gabay C; Palmer G
    Arthritis Res Ther; 2013 Jan; 15(1):R13. PubMed ID: 23324173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.
    García S; Forteza J; López-Otin C; Gómez-Reino JJ; González A; Conde C
    Arthritis Res Ther; 2010; 12(6):R224. PubMed ID: 21190566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
    Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
    Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia inhibitory factor, interleukin-6, and their receptors are expressed transiently in the olfactory mucosa after target ablation.
    Nan B; Getchell ML; Partin JV; Getchell TV
    J Comp Neurol; 2001 Jun; 435(1):60-77. PubMed ID: 11370011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis.
    Singh A; Rajasekaran N; Hartenstein B; Szabowski S; Gajda M; Angel P; Bräuer R; Illges H
    Arthritis Res Ther; 2013; 15(6):R222. PubMed ID: 24369907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive pro-inflammatory gene signatures induced in articular chondrocytes by oncostatin M and IL-6 are regulated by Suppressor of Cytokine Signaling-3.
    Liu X; Liu R; Croker BA; Lawlor KE; Smyth GK; Wicks IP
    Osteoarthritis Cartilage; 2015 Oct; 23(10):1743-54. PubMed ID: 26045176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
    Hui W; Bell M; Carroll G
    Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of arthritis severity in protease-activated receptor-deficient mice.
    Yang YH; Hall P; Little CB; Fosang AJ; Milenkovski G; Santos L; Xue J; Tipping P; Morand EF
    Arthritis Rheum; 2005 Apr; 52(4):1325-32. PubMed ID: 15818676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
    O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
    Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
    Lamacchia C; Rodriguez E; Palmer G; Vigne S; Martin P; Talabot-Ayer D; Seemayer CA; Gabay C
    Ann Rheum Dis; 2012 Feb; 71(2):281-7. PubMed ID: 22072017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.
    Okamoto H; Yamamura M; Morita Y; Harada S; Makino H; Ota Z
    Arthritis Rheum; 1997 Jun; 40(6):1096-105. PubMed ID: 9182920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
    Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
    Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
    Palmqvist P; Persson E; Conaway HH; Lerner UH
    J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF.
    Liu F; Aubin JE; Malaval L
    Bone; 2002 Jul; 31(1):212-9. PubMed ID: 12110437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves.
    Ito Y; Yamamoto M; Li M; Doyu M; Tanaka F; Mutch T; Mitsuma T; Sobue G
    Brain Res; 1998 May; 793(1-2):321-7. PubMed ID: 9630704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.